Gary Aston-Jones
Affiliations: | Medical University of South Carolina, Charleston, SC, United States |
Area:
neuropharmacologyGoogle:
"Gary Aston-Jones"Mean distance: 11.85 (cluster 40) | S | N | B | C | P |
Parents
Sign in to add mentorJames Olds | grad student | MUSC | |
Stuart H. Thompson | grad student | Stanford | |
Simon Alford | post-doc | MUSC | |
Floyd E. Bloom | post-doc | The Salk Institute for Biological Studies |
Children
Sign in to add trainee
BETA: Related publications
See more...
Publications
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
James MH, Fragale JE, O'Connor SL, et al. (2020) The orexin (hypocretin) neuropeptide system is a target for novel therapeutics to treat cocaine use disorder with alcohol co-abuse. Neuropharmacology. 108359 |
Fragale JE, James MH, Aston-Jones G. (2020) Intermittent self-administration of fentanyl induces a multifaceted addiction state associated with persistent changes in the orexin system. Addiction Biology. e12946 |
Freeman LR, Bentzley BS, James MH, et al. (2020) Sex Differences in Demand for Highly Palatable Foods: Role of the Orexin System. The International Journal of Neuropsychopharmacology |
James MH, Fragale JE, Aurora RN, et al. (2020) Repurposing the dual orexin receptor antagonist suvorexant for the treatment of opioid use disorder: why sleep on this any longer? Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology |
James MH, Aston-Jones G. (2020) Introduction to the Special Issue: "Orexin/hypocretin receptor antagonists for the treatment of addiction and related psychiatric disease: What are the steps from here?" Brain Research. 146665 |
Gu Y, Piper WT, Branigan LA, et al. (2019) A brainstem-central amygdala circuit underlies defensive responses to learned threats. Molecular Psychiatry |
Hamlett ED, Ledreux A, Gilmore A, et al. (2019) Inhibitory designer receptors aggravate memory loss in a mouse model of down syndrome. Neurobiology of Disease. 134: 104616 |
Mohammadkhani A, Fragale JE, Pantazis CB, et al. (2019) Orexin-1 receptor signaling in ventral pallidum regulates motivation for the opioid remifentanil. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience |
Mohammadkhani A, James MH, Pantazis CB, et al. (2019) Persistent effects of the orexin-1 receptor antagonist SB-334867 on motivation for the fast acting opioid remifentanil. Brain Research. 146461 |
Pantazis CB, James MH, Bentzley BS, et al. (2019) The number of lateral hypothalamus orexin/hypocretin neurons contributes to individual differences in cocaine demand. Addiction Biology. e12795 |